These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11560066)

  • 1. Data mining of spectroscopic data for biomarker discovery.
    Norton SM; Huyn P; Hastings CA; Heller JC
    Curr Opin Drug Discov Devel; 2001 May; 4(3):325-31. PubMed ID: 11560066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ; Veenstra TD
    Electrophoresis; 2007 Jun; 28(12):1980-8. PubMed ID: 17503404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-source tools for data mining.
    Zupan B; Demsar J
    Clin Lab Med; 2008 Mar; 28(1):37-54, vi. PubMed ID: 18194717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
    Serkova NJ; Niemann CU
    Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational biology for cardiovascular biomarker discovery.
    Azuaje F; Devaux Y; Wagner D
    Brief Bioinform; 2009 Jul; 10(4):367-77. PubMed ID: 19276200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical strategies in lipidomics and applications in disease biomarker discovery.
    Hu C; van der Heijden R; Wang M; van der Greef J; Hankemeier T; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2836-46. PubMed ID: 19233743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data mining methods in Omics-based biomarker discovery.
    Zhang F; Chen JY
    Methods Mol Biol; 2011; 719():511-26. PubMed ID: 21370100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery.
    Gowda GA; Ijare OB; Shanaiah N; Bezabeh T
    Biomark Med; 2009 Jun; 3(3):307-22. PubMed ID: 20477478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology.
    Coen M; Holmes E; Lindon JC; Nicholson JK
    Chem Res Toxicol; 2008 Jan; 21(1):9-27. PubMed ID: 18171018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Algorithms and tools for analysis and management of mass spectrometry data.
    Veltri P
    Brief Bioinform; 2008 Mar; 9(2):144-55. PubMed ID: 18356204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of mass spectrometry in metabolite profiling and characterization.
    Want EJ; Cravatt BF; Siuzdak G
    Chembiochem; 2005 Nov; 6(11):1941-51. PubMed ID: 16206229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining for biomarker development: a review of tissue specificity analysis.
    Klee EW
    Clin Lab Med; 2008 Mar; 28(1):127-43, viii. PubMed ID: 18194723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers: current perspectives and future prospects.
    Naylor S
    Expert Rev Mol Diagn; 2003 Sep; 3(5):525-9. PubMed ID: 14510173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.